A Call to Accelerate Hidradenitis Suppurativa Research and Improve Care-Moving Beyond Burden.
作者信息
Naik Haley B, Lowes Michelle A
机构信息
Department of Dermatology, University of California, San Francisco.
The Rockefeller University, New York, New York.
出版信息
JAMA Dermatol. 2019 Sep 1;155(9):1005-1006. doi: 10.1001/jamadermatol.2019.1105.
Abstract
摘要
相似文献
1
A Call to Accelerate Hidradenitis Suppurativa Research and Improve Care-Moving Beyond Burden.呼吁加速化脓性汗腺炎研究并改善护理——超越负担。
JAMA Dermatol. 2019 Sep 1;155(9):1005-1006. doi: 10.1001/jamadermatol.2019.1105.
2
Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool.使用化脓性汗腺炎疾病负担工具评估化脓性汗腺炎患者术后的生活质量。
Cureus. 2021 Feb 6;13(2):e13172. doi: 10.7759/cureus.13172.
3
What causes hidradenitis suppurativa ?-15 years after.化脓性汗腺炎的病因是什么？——15 年后的研究进展
Exp Dermatol. 2020 Dec;29(12):1154-1170. doi: 10.1111/exd.14214.
4
Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections.阿达木单抗、甲氨蝶呤及皮损内注射糖皮质激素有效维持治疗化脓性汗腺炎伴滑膜炎、痤疮、脓疱病、骨肥厚和骨炎综合征。
SAGE Open Med Case Rep. 2018 Jun 1;6:2050313X18778723. doi: 10.1177/2050313X18778723. eCollection 2018.
5
A gene dysfunction module reveals the underlying pathogenesis of hidradenitis suppurativa: An update.基因功能障碍模块揭示了化脓性汗腺炎的潜在发病机制：更新。
Australas J Dermatol. 2020 Feb;61(1):e10-e14. doi: 10.1111/ajd.13107. Epub 2019 Jul 2.
6
The Value of Negative-Pressure Wound Therapy and Flap Surgery in Hidradenitis Suppurativa - A Single Center Analysis of Different Treatment Options.负压伤口治疗与皮瓣手术在化脓性汗腺炎中的价值——不同治疗方案的单中心分析
Front Surg. 2022 Jun 28;9:867487. doi: 10.3389/fsurg.2022.867487. eCollection 2022.
7
Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019.第四届化脓性汗腺炎进展研讨会报告 2019 年。
J Am Acad Dermatol. 2021 Jan;84(1):120-129. doi: 10.1016/j.jaad.2020.05.114. Epub 2020 Jun 1.
8
Case report of hidradenitis suppurativa localized to the face in an HIV patient.1例人类免疫缺陷病毒（HIV）患者面部局限性化脓性汗腺炎病例报告
SAGE Open Med Case Rep. 2021 Nov 9;9:2050313X211057923. doi: 10.1177/2050313X211057923. eCollection 2021.
9
Hidradenitis Suppurativa, Intimate Partner Violence, and Sexual Assault.化脓性汗腺炎、亲密伴侣暴力与性侵犯
J Cutan Med Surg. 2017 Sep/Oct;21(5):383-387. doi: 10.1177/1203475417708167. Epub 2017 May 8.
10
Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.阿达木单抗用于治疗化脓性汗腺炎的临床经验。与克罗恩病的缓解率比较。
Actas Dermosifiliogr. 2016 Sep;107 Suppl 2:43-50. doi: 10.1016/S0001-7310(17)30008-X.
引用本文的文献
1
The Inflammatory Landscape of a Whole-Tissue Explant Model of Hidradenitis Suppurativa.化脓性汗腺炎全组织外植体模型的炎症图谱
Exp Dermatol. 2025 Feb;34(2):e70057. doi: 10.1111/exd.70057.
2
How Digital Solutions Might Provide a World of New Opportunities for Holistic and Empathic Support of Patients with Hidradenitis Suppurativa.数字解决方案如何为化脓性汗腺炎患者提供全面且具同理心支持的全新机遇世界。
Dermatol Ther (Heidelb). 2024 Aug;14(8):1975-1981. doi: 10.1007/s13555-024-01234-9. Epub 2024 Jul 23.
3
Sex-biased immunological processes drive hidradenitis suppurativa.性别偏向的免疫过程导致化脓性汗腺炎。
Front Immunol. 2023 May 4;14:1167021. doi: 10.3389/fimmu.2023.1167021. eCollection 2023.
4
Recent advances in hidradenitis suppurativa: Role of race, genetics, and immunology.化脓性汗腺炎的最新进展：种族、遗传学和免疫学的作用
Front Genet. 2022 Aug 26;13:918858. doi: 10.3389/fgene.2022.918858. eCollection 2022.
5
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.在化脓性汗腺炎中鉴定生物标志物及对生物标志物验证的关键性评估：系统综述。
JAMA Dermatol. 2022 Mar 1;158(3):300-313. doi: 10.1001/jamadermatol.2021.4926.
6
The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.化脓性汗腺炎皮肤的炎症蛋白质组比寻常型银屑病更广泛。
J Am Acad Dermatol. 2022 Feb;86(2):322-330. doi: 10.1016/j.jaad.2021.07.035. Epub 2021 Jul 30.
7
Bibliometric Analysis of the 50 Most Cited Publications in Hidradenitis Suppurativa.化脓性汗腺炎领域被引用次数最多的50篇出版物的文献计量分析。
Skin Appendage Disord. 2021 Apr;7(3):173-179. doi: 10.1159/000513771. Epub 2021 Feb 18.
8
Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care.标准化命名法对推进化脓性汗腺炎研究及临床护理的重要性。
JAMA Dermatol. 2021 Apr 1;157(4):381-383. doi: 10.1001/jamadermatol.2020.5466.
9
The most recent advances in understanding and managing hidradenitis suppurativa.化脓性汗腺炎的理解与管理方面的最新进展。
F1000Res. 2020 Aug 26;9. doi: 10.12688/f1000research.26083.1. eCollection 2020.
10
Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.化脓性汗腺炎的免疫发病机制和抗 TNF-α 治疗反应。
JCI Insight. 2020 Oct 2;5(19):139932. doi: 10.1172/jci.insight.139932.
本文引用的文献
1
Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.化脓性汗腺炎与炎症性肠病的关联：一项系统评价和荟萃分析。
JAMA Dermatol. 2019 Sep 1;155(9):1022-1027. doi: 10.1001/jamadermatol.2019.0891.
2
Depression and Anxiety in Adults With Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.化脓性汗腺炎成人患者的抑郁与焦虑：一项系统评价与荟萃分析
JAMA Dermatol. 2019 Aug 1;155(8):939-945. doi: 10.1001/jamadermatol.2019.0759.
3
Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa.比较化脓性汗腺炎患者的总体合并症负担。
JAMA Dermatol. 2019 Jul 1;155(7):797-802. doi: 10.1001/jamadermatol.2019.0164.
4
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.北美化脓性汗腺炎临床管理指南：美国和加拿大化脓性汗腺炎基金会的出版物：第一部分：诊断、评估和补充及程序管理的应用。
J Am Acad Dermatol. 2019 Jul;81(1):76-90. doi: 10.1016/j.jaad.2019.02.067. Epub 2019 Mar 11.
5
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.北美化脓性汗腺炎临床管理指南：美国和加拿大化脓性汗腺炎基金会联合发布：第二部分：局部、皮损内和全身医学治疗。
J Am Acad Dermatol. 2019 Jul;81(1):91-101. doi: 10.1016/j.jaad.2019.02.068. Epub 2019 Mar 11.
6
Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus.寻常型天疱疮和落叶型天疱疮患者的 EQ-5D 量表的有效性。
Br J Dermatol. 2019 Apr;180(4):802-809. doi: 10.1111/bjd.16883. Epub 2018 Sep 19.
7
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.基于人群的临床实践研究数据库研究使用算法模型来确定化脓性汗腺炎的真实负担。
Br J Dermatol. 2018 Apr;178(4):917-924. doi: 10.1111/bjd.16101. Epub 2018 Feb 22.
8
Increased Suicide Risk in Patients with Hidradenitis Suppurativa.患有化脓性汗腺炎的患者自杀风险增加。
J Invest Dermatol. 2018 Jan;138(1):52-57. doi: 10.1016/j.jid.2017.09.008. Epub 2017 Sep 20.
9
Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States.美国化脓性汗腺炎患病率估计值的性别和年龄调整人口分析。
JAMA Dermatol. 2017 Aug 1;153(8):760-764. doi: 10.1001/jamadermatol.2017.0201.
10
Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study.化脓性汗腺炎患者的生活质量损害：一项加拿大的研究。
Am J Clin Dermatol. 2015 Feb;16(1):61-5. doi: 10.1007/s40257-014-0105-5.
Zotero 插件